News
Eliminating hepatitis by 2030: HHS releases new strategic plan
- Author:
- Mark S. Lesney, PhD
The United States “is currently facing unprecedented hepatitis A outbreaks, while progress in preventing hepatitis B has stalled, and hepatitis C...
News
Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A
- Author:
- Mark S. Lesney, PhD
Inhibitors occurred at an early age of 13 years with a prevalence of 2.6%, but were not associated with increased mortality.
News
Study shows no link between race and mortality in clear cell RCC
- Author:
- Mark S. Lesney, PhD
Older age and having regional or distant tumors were associated with an increased risk of death, while female...
News
‘Excellent short-term outcomes’ seen in HCV+ liver transplants to HCV– recipients
- Author:
- Mark S. Lesney, PhD
Liver transplantation using HCV-seropositive grafts to HCV-seronegative recipients resulted in “excellent short-...
News
Circulating miRNA could be a potential biomarker for early diagnosis of MM
- Author:
- Mark S. Lesney, PhD
A meta-analysis found that using circulating microRNAs had high sensitivity and specificity in the early diagnosis of multiple myeloma.
News
Pigment traits, sun sensitivity associated with risk of non-Hodgkin lymphomas and chronic lymphocytic leukemia
- Author:
- Mark S. Lesney, PhD
The presence of “many or very many nevi [moles]” was particularly associated with the risk of CLL.
News
Combo DAA treatments may benefit patients with resistant HCV genotype 3
- Author:
- Mark S. Lesney, PhD
A variety of combo drug treatments proved effective in treating HCV genotype 3 to achieve sustained virologic response.
News
Hemophilia, von Willebrand disease do not increase postop complications for ACL reconstruction
- Author:
- Mark S. Lesney, PhD
A case-control study showed outcomes were similar but hospital costs were significantly higher for patients with bleeding disorders.
Article
Opt-out policy at a syringe service program increased HIV/HCV testing
- Author:
- Mark S. Lesney, PhD
For HIV and HCV among people who inject drugs, it is important to improve diagnosis and linkage to care.
News
Ibrutinib associated with decreased circulating malignant cells and restored T-cell function in CLL patients
- Author:
- Mark S. Lesney, PhD
Ibrutinib showed decreased circulating malignant immune cells and restored healthy T-cell function in chronic...
News
Whales, seals, and dolphins: Will SARS-CoV-2–contaminated wastewater prove a killer?
- Author:
- Mark S. Lesney, PhD
Environmental pollution during the COVID-19 pandemic puts dolphins, whales, seals, and otters among the sea...
News
Mouth splints decrease risk of post–dental extraction bleeding in hemophilia
- Author:
- Mark S. Lesney, PhD
On average, post–dental extraction bleeding occurred 6 days after intervention and on the 5th postoperative day...
News
Socioeconomic factors affect survival of multiple myeloma patients
- Author:
- Mark S. Lesney, PhD
Socioeconomic factors such as insurance and income play a significant role in creating survival disparities...
News
ESMO offers new clinical practice guideline for CLL
- Author:
- Mark S. Lesney, PhD
New chronic lymphocytic leukemia guideline addresses diagnosis, treatment, and follow-up.
Article
Older age, r/r disease in lymphoma patients tied to increased COVID-19 death rate
- Author:
- Mark S. Lesney, PhD
Patients younger than 70 years, without relapsed/refractory lymphoma had an 88% 30-day overall survival,...